智云健康在港交所上市，保持初心，始终以患者为中心，致力于让数字健康走进千家万户 ClouDr Group's listing on the Hong Kong Stock Exchange marks a significant milestone in our journey. We remain true to our original aspiration, steadfastly focusing on patients and committed to bringing digital health into every household.

双SaaS系统、智云健康APP、智云医生APP等产品矩阵，形成“医患药付”一站式慢病管理生态，实现自我造血获得市场认可 The dual SaaS system, ClouDr APP, Dr ClouDr and other product matrices have formed a one-stop chronic disease management ecosystem of "doctors, patients, drug, payment". ClouDr has achieved self-growth and gained market recognition.

合作医院近1000家，业务收入实现300%的增长 Close to 1,000 partner hospitals; 300% growth in revenues Team expanded with many talents from leaders in the medical and internet industries, such as Johnson & Johnson, Kanghong Pharmaceutical, and Alibaba, among others

吸引大批来自强生、康弘药业、阿里巴巴等医疗与互联网头部公司优秀人才加入

Hangzhou Kangsheng Health Management and Consulting Co., Ltd. founded.

Our mission: Leverage internet technologies to build stronger trust between doctors and patients, make healthcare more efficient and to improve the allocation of medical resources

智云快药，智云药城助力中小药店逆势增长；互联网医疗服务拓展线上场景，成为国内最大线上医疗服务器；升级智云医疗大脑，推出两个医疗行业模型-ClouDGPT、ClouD DTx ClouDr Express, the B2B one-stop procurement, and ClouDr Drug City O2O help small and medium-sized pharmacies to grow. The Internet medical service has been expanded to online scenarios such as Meituan, Ali, etc., and the average daily number of consultation services has exceeded 900,000 times, becoming the largest online medical service provider in China. We upgraded our medical brain and launched two medical industry models - ClouD GPT and CIouD DTx.

布局高端智造宝利化制药品牌重塑，打造科技创新驱动与数字研发的现代化制药集团，加强数字化和智能化技术竞争力 Lay out the brand of Polifarma Pharmaceutical in the high-end intelligent manufacturing sector, create a modern pharmaceutical group driven by scientific and technological innovation and digital research and development, and strengthen the competitiveness of digital and intelligent technologies.

建立了院内院外、线上线下联合的数字化慢病全生命周期管理的创新生态体系，提出“健康中国2030计划”，部署线下健康小站 It has established an innovative ecosystem for the full-life cycle management of chronic diseases, integrating both in-hospital and out-of-hospital, as well as online and offline approaches. It has put forward the "Healthy China 2030 Plan" and deployed health stations.

开拓院外场景，上线药店SaaS系统——智云问诊，年底前已覆盖3005家，持续拓展慢病生态链，全面提升技术与服务品质 Exploring out-of-hospital market and launch the pharmacy SaaS system, "ClouDr Consultation". By the end of the year, we have covered 3,005 pharmacies. We will expand the ecosystem of chronic disease management, aiming to comprehensively enhance technology and service quality.

业务战略全面升级，服务范围由糖尿病延展至整个慢病领域，同时品牌名称升级为“智云健康”，成为中国最大的数字化慢病管理解决方案提供商 The business strategy has been upgraded. The service scope has been extended from diabetes to the entire chronic disease field. Meanwhile, the brand name has been upgraded to ClouDr Group, which is the largest provider of digital chronic disease management solutions in China.